Device-based disease-modifying therapies for Alzheimer's and dementia Companies

1 organization in the Device-based disease-modifying therapies for Alzheimer's and dementia market segment

NeuroEM Therapeutics, Inc.

NeuroEM Therapeutics is a clinical-stage biotech developing non-invasive, drug-free approaches to reverse cognitive decline caused by Alzheimer's and other neurodegenerative diseases.